PHIBRO ANIMAL HEALTH CORP — insider transactions
5 transactions on record · CIK 1069899
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
5
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
3
Bought, 3m
$0
Sold, 3m
$102.1K
Median disclosure lag
4.0 d
trade date to filing date
Largest single trade, 24m
$84.3K
2026-08-04
Director share, 12m
60.0%
of transactions where role is stated
Current run
5 sells
consecutive same-direction transactions
Net 3m flow
-$102.1K
purchases minus sales
Total on record
5
Transactions
5 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-10 | 2026-08-06 | 4 | BENDHEIM Jonathan | Director | Grant or award | 2,716 | $0.00 | — | filing |
| 2026-08-10 | 2026-08-06 | 4 | BFI Co., LLC | 10% Owner | Grant or award | 12,103 | $0.00 | — | filing |
| 2026-08-10 | 2026-08-06 | 4 | Bendheim Daniel M | Director, President and CEO | Grant or award | 11,699 | $0.00 | — | filing |
| 2026-08-06 | 2026-08-04 | 2 | BFI Co., LLC | 10% Owner | Other acquisition or disposition | 2,303 | $36.60 | $84.3K | filing |
| 2026-08-06 | 2026-08-04 | 2 | Bendheim Daniel M | Director, President and CEO | Other acquisition or disposition | 486 | $36.60 | $17.8K | filing |